255 related articles for article (PubMed ID: 21888685)
1. Cardiovascular disease in systemic sclerosis--an emerging association?
Ngian GS; Sahhar J; Wicks IP; Van Doornum S
Arthritis Res Ther; 2011 Aug; 13(4):237. PubMed ID: 21888685
[TBL] [Abstract][Full Text] [Related]
2. A critical view on cardiovascular risk in systemic sclerosis.
Psarras A; Soulaidopoulos S; Garyfallos A; Kitas G; Dimitroulas T
Rheumatol Int; 2017 Jan; 37(1):85-95. PubMed ID: 27405985
[TBL] [Abstract][Full Text] [Related]
3. Is atherosclerosis accelerated in systemic sclerosis? Novel insights.
Soriano A; Afeltra A; Shoenfeld Y
Curr Opin Rheumatol; 2014 Nov; 26(6):653-7. PubMed ID: 25198242
[TBL] [Abstract][Full Text] [Related]
4. The burden and measurement of cardiovascular disease in SSc.
Mok MY; Lau CS
Nat Rev Rheumatol; 2010 Jul; 6(7):430-4. PubMed ID: 20517296
[TBL] [Abstract][Full Text] [Related]
5. Early morphologic and functional changes of atherosclerosis in systemic sclerosis-a systematic review and meta-analysis.
Meiszterics Z; Tímár O; Gaszner B; Faludi R; Kehl D; Czirják L; Szűcs G; Komócsi A
Rheumatology (Oxford); 2016 Dec; 55(12):2119-2130. PubMed ID: 27565177
[TBL] [Abstract][Full Text] [Related]
6. Circulating endothelial progenitor cells in systemic sclerosis: relation to impaired angiogenesis and cardiovascular manifestations.
Nevskaya T; Bykovskaia S; Lyssuk E; Shakhov I; Zaprjagaeva M; Mach E; Ananieva L; Guseva N; Nassonov E
Clin Exp Rheumatol; 2008; 26(3):421-9. PubMed ID: 18578963
[TBL] [Abstract][Full Text] [Related]
7. Ischemic arterial events and atherosclerosis in patients with systemic sclerosis: a population-based case-control study.
Nordin A; Jensen-Urstad K; Björnådal L; Pettersson S; Larsson A; Svenungsson E
Arthritis Res Ther; 2013 Aug; 15(4):R87. PubMed ID: 23945149
[TBL] [Abstract][Full Text] [Related]
8. Atherosclerosis and macrovascular involvement in systemic sclerosis: myth or reality.
Nussinovitch U; Shoenfeld Y
Autoimmun Rev; 2011 Mar; 10(5):259-66. PubMed ID: 20863903
[TBL] [Abstract][Full Text] [Related]
9. Systemic Sclerosis and Atherosclerosis: Potential Cellular Biomarkers and Mechanisms.
Gerasimova EV; Shayakhmetova RU; Gerasimova DA; Popkova TV; Ananyeva LP
Front Biosci (Schol Ed); 2023 Dec; 15(4):16. PubMed ID: 38163957
[TBL] [Abstract][Full Text] [Related]
10. The role of asymmetric dimethylarginine in endothelial dysfunction and abnormal nitric oxide metabolism in systemic sclerosis: results from a pilot study.
Pagkopoulou E; Soulaidopoulos S; Katsiki N; Malliari A; Loutradis C; Karagiannis A; Doumas M; Garyfallos A; Kitas G; Dimitroulas T
Clin Rheumatol; 2023 Apr; 42(4):1077-1085. PubMed ID: 36534350
[TBL] [Abstract][Full Text] [Related]
11. Macrovascular disease and atherosclerosis in SSc.
Hettema ME; Bootsma H; Kallenberg CG
Rheumatology (Oxford); 2008 May; 47(5):578-83. PubMed ID: 18321944
[TBL] [Abstract][Full Text] [Related]
12. Myocardial fibrosis detected by magnetic resonance imaging, elevated U-CRP and higher mRSS are predictors of cardiovascular complications in systemic sclerosis (SSc) patients.
Rodríguez-Reyna TS; Rosales-Uvera SG; Kimura-Hayama E; Hernández-Reyes P; Mercado-Velázquez P; Benavides-Suárez SA; Esquinca-González A; Núñez-Álvarez CA
Semin Arthritis Rheum; 2019 Oct; 49(2):273-278. PubMed ID: 30853116
[TBL] [Abstract][Full Text] [Related]
13. Early atherosclerosis in systemic sclerosis and its relation to disease or traditional risk factors.
Hettema ME; Zhang D; de Leeuw K; Stienstra Y; Smit AJ; Kallenberg CG; Bootsma H
Arthritis Res Ther; 2008; 10(2):R49. PubMed ID: 18439295
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular magnetic resonance in systemic sclerosis: "Pearls and pitfalls".
Mavrogeni SI; Schwitter J; Gargani L; Pepe A; Monti L; Allanore Y; Matucci-Cerinic M
Semin Arthritis Rheum; 2017 Aug; 47(1):79-85. PubMed ID: 28522072
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D deficiency is associated with digital ulcer but not with atherosclerosis or arterial stiffness in patients with systemic sclerosis: a pilot study.
Park EK; Park JH; Kweon SM; Kim GT; Lee SG
Clin Rheumatol; 2017 Jun; 36(6):1325-1333. PubMed ID: 28365806
[TBL] [Abstract][Full Text] [Related]
16. Endothelial dysfunction precedes atherosclerosis in systemic sclerosis--relevance for prevention of vascular complications.
Szucs G; Tímár O; Szekanecz Z; Dér H; Kerekes G; Szamosi S; Shoenfeld Y; Szegedi G; Soltész P
Rheumatology (Oxford); 2007 May; 46(5):759-62. PubMed ID: 17244666
[TBL] [Abstract][Full Text] [Related]
17. Silent cardiovascular involvement in patients with diffuse systemic sclerosis: a controlled cross-sectional study.
Turiel M; Gianturco L; Ricci C; Sarzi-Puttini P; Tomasoni L; Colonna Vde G; Ferrario P; Epis O; Atzeni F
Arthritis Care Res (Hoboken); 2013 Feb; 65(2):274-80. PubMed ID: 22899452
[TBL] [Abstract][Full Text] [Related]
18. Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry.
Tolosa-Vilella C; Morera-Morales ML; Simeón-Aznar CP; Marí-Alfonso B; Colunga-Arguelles D; Callejas Rubio JL; Rubio-Rivas M; Freire-Dapena M; Guillén-Del Castillo A; Iniesta-Arandia N; Castillo-Palma MJ; Egurbide-Arberas M; Trapiellla-Martínez L; Vargas-Hitos JA; Todolí-Parra JA; Rodriguez-Carballeira M; Marin-Ballvé A; Pla-Salas X; Rios-Blanco JJ; Fonollosa-Pla V;
Semin Arthritis Rheum; 2016 Oct; 46(2):200-208. PubMed ID: 27312381
[TBL] [Abstract][Full Text] [Related]
19. Is there evidence for vasculitis in systemic sclerosis?
Saketkoo LA; Distler O
Curr Rheumatol Rep; 2012 Dec; 14(6):516-25. PubMed ID: 23065452
[TBL] [Abstract][Full Text] [Related]
20. [Systemic sclerosis and macrovascular involvement: Status of the issue in 2019].
Bertolino J; Scafi M; Benyamine A; Aissi K; Boufi M; Schleinitz N; Sarlon G; Rossi P; Granel B
J Med Vasc; 2019 Dec; 44(6):400-421. PubMed ID: 31761307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]